Delaware
|
1-11700
|
04-2869857
|
|||
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No. )
|
|||
9033 Red Branch Road, Columbia, MD
|
|||||
21045
|
|||||
(Address of Principal Executive Offices)
|
(Zip Code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
·
|
Requiring stockholders to give notice of stockholder proposals and nominations to the Board of Directors not less than 60 nor more than 90 days prior to the one-year anniversary of the date that the Company mailed its proxy materials for the preceding years annual meeting or, for a special meeting, not later than the 10th day following public announcement of the meeting.
|
|
·
|
Requiring that a stockholder proposal to the Board of Directors include certain disclosures about the proposal including a description of the proposal, the reasons for the proposal and any interest that the stockholder has in the proposal.
|
|
·
|
Requiring the notice of a stockholder nomination to make certain disclosures about the proposed nominee, including biographical, stock ownership and investment intent information and all other information about the proposed nominee that is required in the solicitation of proxies in an election contest or otherwise required pursuant to Regulation 14A under the Securities Exchange Act of 1934.
|
|
·
|
Requiring the notice of a stockholder proposal or nomination to make certain disclosures regarding the stockholder giving the notice and specified persons associated with such stockholder, including stock ownership information for and any hedging activity or other similar arrangements entered into by such persons.
|
|
·
|
Requiring a stockholder to verify the accuracy or completeness of any information contained in a stockholder proposal or nomination at the Company’s request and stating that a stockholder proposal or nomination that is inaccurate or incomplete in any manner shall be disregarded.
|
|
·
|
Permitting the Company to provide notice electronically for meetings of shareholders and directors to the extent permitted by Delaware law.
|
|
·
|
Expanding the indemnification provisions applicable to current and former directors and officers of the Company to permit indemnification and advancement of expenses to the full extent authorized by applicable law.
|
|
·
|
Establishing that any amendment to the indemnification and advancement of expenses provisions applicable to current and former directors and officers of the Company are prospective in nature only.
|
Exhibit No.
|
Description
|
||
3
|
|
Amended and Restated Bylaws of Hemagen Diagnostics, Inc.
|
HEMAGEN DIAGNOSTICS, INC.
|
|||
Date: March 29, 2010
|
By:
|
/s/ William P. Hales | |
William P. Hales | |||
Chairman, President and Chief Executive Officer
|
|||